# Womea — full content index

> Evidence-based menopause and midlife medicine, prescribed online by licensed US clinicians. Body-identical hormone therapy, delivered to your door.

Womea leads with guideline-concordant hormone therapy and follows The Menopause Society and ACOG. We do not claim compounded "bioidentical" hormones are safer or more natural. We also offer compounded Biest (estradiol + estriol), with or without progesterone; compounded hormones, including estriol, are compounded individually by a state-licensed 503A pharmacy rather than mass-manufactured to a standardized, tested product. Menopause is symptom-diagnosed — no bloodwork is required to begin. Cash-pay, à la carte, no membership fee, free shipping, cancel anytime.

## Treatments by symptom

### Hot flashes & night sweats
Path: /treatments/hot-flashes

Yes — hot flashes and night sweats are highly treatable, and hormone therapy is the most effective option available. They're driven by changes in the brain's temperature-regulation center as estrogen falls, which narrows your comfortable temperature range. They are not something to simply endure: with the right treatment, most women feel meaningful relief within weeks.

Symptoms: Sudden waves of heat in the face, neck, and chest; Drenching night sweats that disrupt sleep; Flushing, sweating, and chills; Racing heart during a flash

- The Menopause Society, 2023: Hormone therapy is the most effective treatment for vasomotor symptoms, and is appropriate for healthy symptomatic women who are within 10 years of menopause or younger than 60.
- The Menopause Society, 2022 Hormone Therapy Position Statement: Hormone therapy has both benefits and risks; the decision to treat is individualized with a licensed clinician based on symptoms, health history, and preferences.

### Sleep disruption
Path: /treatments/sleep

Yes — treating the hormonal cause of menopause sleep disruption restores sleep for most women, often better than a sleep aid. Poor sleep is usually downstream of night sweats and the loss of progesterone's calming effect. Rather than masking it with sedatives, we treat the hormonal root — which is why so many women find their sleep returns once therapy begins.

Symptoms: Waking from night sweats; Difficulty falling or staying asleep; Early-morning waking; Unrefreshing sleep and daytime fatigue

- The Menopause Society, 2023: Sleep disturbance is common during the menopause transition and is frequently linked to nighttime vasomotor symptoms; treating hot flashes and night sweats with hormone therapy can improve sleep quality.
- The Menopause Society, 2022 Hormone Therapy Position Statement: Micronized progesterone, taken at bedtime, has a mild sedative effect that can support sleep in addition to protecting the uterine lining.

### Mood & brain fog
Path: /treatments/mood-brain-fog

Brain fog and mood changes in menopause are real, usually temporary, and often improve with treatment — they are not a personal failing. Many women describe forgetfulness, trouble finding words, irritability, and low mood during perimenopause and menopause, tracking with fluctuating and falling estrogen. Hormone therapy is not a cognitive enhancer or an antidepressant, but by easing hot flashes and restoring sleep it frequently lifts the fog and steadies mood, and we approach both with appropriate clinical care.

Symptoms: Difficulty concentrating or finding words; Forgetfulness and mental fatigue; Irritability and mood swings; Low mood and loss of motivation

- The Menopause Society: Hormone therapy is not a treatment for depression, but may improve mood symptoms related to the menopause transition.
- The Menopause Society: Many women report problems with memory and concentration during the menopause transition, and modest declines in verbal memory have been demonstrated, but these changes are generally temporary and do not indicate progression to dementia.
- The Menopause Society, 2022 Hormone Therapy Position Statement: Hormone therapy is not recommended at any age solely to prevent cognitive decline or dementia, though it effectively treats vasomotor symptoms and the sleep disruption that can impair concentration.

### Vaginal & urinary (GSM)
Path: /treatments/vaginal-gsm

Yes — low-dose vaginal estrogen is the most effective treatment for GSM, and unlike hot flashes, these symptoms rarely improve without treatment. The genitourinary syndrome of menopause (GSM) affects up to half of postmenopausal women. Low-dose vaginal estradiol restores tissue thickness, elasticity, and moisture directly at the source, with only minimal hormone reaching the bloodstream.

Symptoms: Vaginal dryness and irritation; Painful or uncomfortable intimacy; Urinary urgency or recurrent UTIs; Burning or itching

- The Menopause Society, GSM Position Statement: Low-dose vaginal estrogen is effective for GSM with minimal systemic absorption.
- The Menopause Society, GSM Position Statement: The genitourinary syndrome of menopause affects up to half of postmenopausal women and, unlike vasomotor symptoms, tends to persist or worsen over time without treatment.
- The Menopause Society, GSM Position Statement: The genitourinary syndrome of menopause, driven by estrogen decline, is associated with recurrent urinary tract infections, and low-dose vaginal estrogen can reduce their recurrence in postmenopausal women.

### Bone & longevity (coming soon)
Path: /treatments/bone-longevity

Estrogen loss accelerates bone loss and shifts metabolism in midlife. Womea is building dedicated bone and longevity care so the platform supports you for decades, not just this year. Join the list to hear when it launches.

## Products and pricing

### Estradiol Patches — $159/mo monthly, $139/mo on 3-month billing
Path: /products/estradiol-patches
Form: Transdermal patch, applied twice weekly. Status: Prescription.

A transdermal estradiol patch delivers a steady dose of estrogen through the skin — the form most guidelines favor for its lower clot risk versus oral estrogen. It is the most effective treatment available for vasomotor symptoms like hot flashes and night sweats. We offer the twice-weekly (biweekly) patch.

Benefits: Most effective treatment for hot flashes and night sweats; Steady transdermal dosing, applied twice weekly; Lower clot risk profile than oral estrogen; Guideline-concordant

Dosing: We offer the twice-weekly patch in 0.025–0.1 mg/day strengths. Your clinician selects a starting dose and adjusts based on your symptoms — menopause is diagnosed and titrated by how you feel, not by routine blood panels. Available with 1 or 3-month billing.

Compliance: Hormone therapy has risks as well as benefits; a licensed clinician will review your history to determine whether it is appropriate for you.

### Estradiol Tablets — $79/mo monthly, $69/mo on 3-month billing
Path: /products/estradiol-tablets
Form: Oral tablet, once daily. Status: Prescription.

Oral estradiol is a once-daily tablet that treats hot flashes, night sweats, and related symptoms of the menopause transition. Your clinician will help you decide between oral and transdermal estrogen based on your history.

Benefits: 17β-estradiol; Simple once-daily tablet; Effective for hot flashes and night sweats

Dosing: Taken once daily in standard strengths. Your clinician selects the dose, discusses oral versus transdermal options, and titrates by your symptoms rather than routine blood panels. Available with 1 or 3-month billing.

Compliance: Hormone therapy has risks as well as benefits; eligibility is determined by a licensed clinician.

### Estradiol Gel — $99/mo monthly, $89/mo on 3-month billing
Path: /products/estradiol-gel
Form: Transdermal gel, applied daily. Status: Prescription.

A transdermal estradiol gel delivers estrogen through the skin — the same lower-clot-risk route as the patch, in a daily gel some women prefer to an adhesive. It treats hot flashes, night sweats, and related symptoms, with a dose your clinician can fine-tune.

Benefits: Transdermal route with a lower clot risk than oral estrogen; Daily gel — no adhesive, good if patches irritate your skin; Flexible, finely adjustable dosing; Guideline-concordant

Dosing: Applied once daily in a metered dose your clinician sets and titrates to your symptoms — menopause is guided by how you feel, not routine blood panels. Allow the gel to dry before dressing. Available with 1 or 3-month billing.

Compliance: Hormone therapy has risks as well as benefits; eligibility is determined by a licensed clinician.

### Progesterone Capsules — $59/mo monthly, $49/mo on 3-month billing
Path: /products/progesterone-capsules
Form: Oral capsule, at bedtime. Status: Prescription.

Micronized progesterone is body-identical and taken at night. It supports sleep and mood and provides uterine protection when paired with estrogen.

Benefits: Supports deeper, more consolidated sleep; Body-identical; Protects the uterine lining alongside estrogen

Dosing: Typically 100–200 mg at bedtime, set by your clinician.

Compliance: A licensed clinician determines whether micronized progesterone is appropriate for you.

### Biest 50:50 — $149/mo monthly, $129/mo on 3-month billing
Path: /products/biest-50-50
Form: Compounded (estradiol + estriol). Status: Compounded (503A pharmacy).

Biest 50:50 is a compounded preparation that combines two estrogens — estradiol and estriol — in equal parts, prepared by a licensed compounding pharmacy. We offer it as a personalization option for women who, with their clinician, choose a compounded approach. We lead with body-identical estradiol; compounded hormones are compounded individually by a state-licensed 503A pharmacy rather than mass-manufactured to a standardized, tested product, and we do not claim Biest is safer or more effective.

Benefits: Combines estradiol and estriol in a 50:50 ratio; Compounded to your clinician's prescription by a licensed pharmacy; A personalization option chosen together with your clinician

Dosing: Your clinician prescribes the strength and a licensed pharmacy compounds it. As with all menopause care, the dose is guided by your symptoms rather than routine blood panels.

Compliance: Biest is a compounded medication. Compounded hormones, including estriol, are compounded individually by a state-licensed 503A pharmacy rather than mass-manufactured to a standardized, tested product. We do not claim Biest is safer, more natural, or more effective than standard hormone therapy. A licensed clinician determines whether it is appropriate for you.

### Biest 50:50 with Progesterone — $189/mo monthly, $169/mo on 3-month billing
Path: /products/biest-50-50-progesterone
Form: Compounded Biest + progesterone. Status: Compounded (503A pharmacy).

Biest 50:50 combined with progesterone, for women with a uterus who choose a compounded estrogen approach. The progesterone protects the uterine lining when estrogen is used. The Biest component is compounded individually by a state-licensed 503A pharmacy rather than mass-manufactured to a standardized, tested product; we lead with body-identical options and do not claim a compounded plan is safer or more effective.

Benefits: Compounded Biest plus progesterone in one plan; Progesterone included for uterine (endometrial) protection; A personalization option chosen together with your clinician

Dosing: Your clinician prescribes the Biest strength and the progesterone dose, compounded by a licensed pharmacy and titrated to your symptoms.

Compliance: The Biest component is a compounded medication. Compounded hormones, including estriol, are compounded individually by a state-licensed 503A pharmacy rather than mass-manufactured to a standardized, tested product. We do not claim this plan is safer, more natural, or more effective than standard hormone therapy. A licensed clinician determines whether it is appropriate for you.

### Estradiol Vaginal Cream — $99/mo monthly, $89/mo on 3-month billing
Path: /products/estradiol-vaginal-cream
Form: Vaginal cream. Status: Prescription.

Low-dose vaginal estradiol cream treats the genitourinary syndrome of menopause (GSM) — vaginal dryness, irritation, painful intimacy, and recurrent urinary symptoms — by restoring local tissue directly, with minimal absorption into the bloodstream.

Benefits: Targets GSM at the source with very low systemic absorption; Relieves dryness, irritation, and painful intimacy; Can reduce recurrent urinary tract infections

Dosing: An initial daily course for a few weeks, then a maintenance schedule (often twice weekly), set by your clinician.

Compliance: Eligibility for vaginal estradiol is determined by a licensed clinician.

## Articles

### Women quietly adapt to menopause in ways most people never notice
Path: /blog/menopause-in-public
Most women in perimenopause or menopause are managing symptoms so that no one notices. We surveyed 1,042 women about what they hide, where they hide it, and what it costs them. Here is the playbook they rarely talk about.

Study: n = 1,042, US women and nonbinary people currently experiencing perimenopause or menopause, fielded 2026-07.
Self-reported survey data from 1,042 women and nonbinary people currently experiencing perimenopause or menopause, covering which symptoms they conceal in public, the settings where concealment is most common, workplace pressure and impacts, the clothing changes and rituals they rely on, and the emotional cost of maintaining composure.

Cite as: Womea, "Women quietly adapt to menopause in ways most people never notice," survey of 1,042 US women and nonbinary people currently experiencing perimenopause or menopause, fielded July 2026. https://womea.com/blog/menopause-in-public

The symptoms women work hardest to conceal in public
| Symptom | Share of women |
| --- | --- |
| Sweating | 56% |
| Hot flashes | 51% |
| Brain fog | 50% |
| Sleep-related fatigue | 45% |
| Mood changes | 43% |
| Facial flushing | 24% |
| Clothing discomfort | 24% |

Public settings where women most often hide symptoms
| Setting | Share of women |
| --- | --- |
| Shopping or running errands | 47% |
| Social event or party | 46% |
| Restaurant or dining out | 39% |
| Family gathering | 37% |
| Traveling (plane, train, etc.) | 26% |
| Exercising | 20% |
| On a date | 15% |

Work situations where women hide menopause symptoms
| Work situation | Share of women |
| --- | --- |
| During a team meeting or group setting | 32% |
| At a work social or client event | 27% |
| During a presentation or speaking in front of others | 25% |
| During a work call or video meeting | 23% |
| During a one-on-one with my manager | 21% |
| During a job interview | 13% |

Work impacts women reported because of menopause
| Impact | Share of women |
| --- | --- |
| Difficulty concentrating | 52% |
| Felt less productive | 48% |
| Difficulty making decisions | 30% |
| Needed additional breaks | 28% |
| Took PTO or called out sick | 18% |
| Left work early | 16% |
| Requested remote work or a flexible schedule | 15% |
| Turned down a job opportunity | 6% |

The workplace supports women most want
| Workplace support | Share of women |
| --- | --- |
| Remote work | 35% |
| Better temperature control | 34% |
| Flexible schedule | 26% |

How menopause has changed what women wear
| Change | Share of women |
| --- | --- |
| Choose comfort over appearance more often | 56% |
| Wear lighter fabrics | 47% |
| Avoid certain fabrics | 36% |
| Dress in layers | 23% |
| Wear darker colors | 21% |
| Change outfits more often | 15% |
| Dress differently for work | 13% |

The rituals women rely on to stay composed
| Ritual | Share of women |
| --- | --- |
| Pre-selected an outfit before leaving home | 56% |
| Left a room or event temporarily | 46% |
| Chose seating for temperature or airflow | 38% |
| Carried a fan or cooling device | 36% |
| Planned the day around cooler environments | 35% |
| Carried makeup or personal care items | 31% |

How women usually feel when menopause symptoms happen in public
| Emotional response | Share of women |
| --- | --- |
| Self-conscious | 43% |
| Frustration | 42% |
| Anxiety | 37% |

### The perimenopause productivity gap: how symptoms cost women at work
Path: /blog/perimenopause-productivity-gap
Perimenopause and menopause symptoms do not stay home when you go to work. We surveyed 831 employed women aged 45 and older about what happens in meetings, on client calls, and in performance reviews. Here is what they told us.

Study: n = 831, employed US women aged 45 and older, fielded 2026-07.
Self-reported survey data from 831 employed US women aged 45 and older who identified as perimenopausal, menopausal, or post-menopausal, covering the effect of symptoms on job performance, working hours lost, career outcomes, and workplace disclosure.

Cite as: Womea, "The perimenopause productivity gap: how symptoms cost women at work," survey of 831 employed US women aged 45 and older, fielded July 2026. https://womea.com/blog/perimenopause-productivity-gap
Independent coverage: Fast Company, https://www.fastcompany.com/91591907/perimenopause-menopause-symptoms-may-cost-employees-nearly-35-workdays-a-year

Symptoms women say disrupted their job performance in the past year
| Symptom | Share of women |
| --- | --- |
| Sleep disruption or fatigue | 63% |
| Brain fog or difficulty concentrating | 58% |
| Anxiety or irritability | 48% |
| Joint pain or physical discomfort | 45% |
| Hot flashes | 39% |
| Mood swings | 31% |
| Decision fatigue | 30% |

Hardest work tasks to do on a symptomatic day
| Task | Share of women |
| --- | --- |
| Multi-tasking | 51% |
| Complex analysis or problem-solving | 40% |
| Making decisions | 34% |
| Public speaking or presenting | 29% |
| Client-facing calls or meetings | 23% |
| Written communication | 12% |
| Meeting tight deadlines | 10% |

How the career cost compounds
| What women reported | Share of women |
| --- | --- |
| Have avoided speaking up in a meeting because of brain fog or anxiety | 38% |
| Have missed a deadline, made a noticeable error, or under-delivered | 35% |
| Have considered reducing their work hours | 23% |
| Have called out sick or used PTO to manage symptoms | 21% |
| Believe symptoms have cost them a promotion, raise, or key project | 17% |
| Are considering leaving their job in the next 12 months | 14% |
| Have turned down a job opportunity they would otherwise have pursued | 12% |

Top reasons women stay silent at work, among those who have told no one
| Reason | Share of women |
| --- | --- |
| Do not think it is their employer's business | 60% |
| Personal discomfort discussing the topic | 31% |
| Fear of stigma or judgment | 29% |
| Fear of being seen as less capable | 28% |
| No formal policy or support exists | 20% |
| Do not have a close relationship with their manager | 16% |

### Is hormone therapy safe? What the evidence says
Path: /science/is-hormone-therapy-safe
For most healthy women under 60 or within ten years of menopause, the benefits of hormone therapy outweigh the risks. Here is what the major trials and current guidelines say — and what they do not.

### Bioidentical vs compounded hormones, explained
Path: /science/fda-approved-vs-compounded-bioidentical-hormones
“Bioidentical” is a marketing word, not a safety claim. Estradiol and progesterone manufactured to a tested, standardized product are body-identical and rigorously tested. Here is how to tell the categories apart — and where compounding has a legitimate, narrow role.

### Treating GSM: vaginal estrogen and DHEA
Path: /science/treating-gsm-vaginal-estrogen-and-dhea
Vaginal dryness, painful intimacy, and recurrent urinary symptoms rarely improve on their own — but they respond well to low-dose local therapy. Here is how vaginal estrogen and DHEA work.

### What to expect in your first 90 days of HRT
Path: /blog/your-first-90-days-of-hrt
Starting hormone therapy is a process, not a switch. Here is an honest timeline of the first three months — what often improves early, what takes longer, and how dose adjustments work.

### Why menopause does not require blood tests to treat
Path: /blog/why-menopause-does-not-require-blood-tests
Many women are told they need hormone bloodwork before they can be treated. For most, that is not true. Menopause is a clinical diagnosis, and treatment is guided by how you feel.

### Transdermal vs oral estrogen: the mechanism and the evidence
Path: /science/transdermal-vs-oral-estrogen-route-matters
Estradiol can be delivered through the skin or swallowed as a pill — and the difference is not cosmetic. Transdermal routes bypass the liver's first pass, which appears to lower clot risk. Here is the mechanism and the evidence behind that difference.

### Estrogen, bone loss, and fracture risk in menopause
Path: /science/estrogen-bone-loss-and-fracture-risk
Estrogen helps keep bone strong, and its decline drives the fastest bone loss of a woman's life in the years around menopause. Hormone therapy is an established option to prevent that loss — within an individualized, risk-aware decision.

### Perimenopause vs menopause: what's the difference
Path: /blog/perimenopause-vs-menopause-difference
Perimenopause is the years of change leading up to your final period; menopause is a single point in time, marked twelve months after. Here is how the two stages are defined and diagnosed — for a closer look at symptoms and timing, see our perimenopause symptoms and timeline guide.

### How to talk to your clinician about hormone therapy
Path: /blog/how-to-talk-to-your-clinician-about-hormone-therapy
The hardest part of getting help is often just starting the conversation. Here is how to prepare, what to ask, and how to make a shared, evidence-based decision about hormone therapy with your clinician.

### Hot flashes: causes, triggers, and how to get relief
Path: /blog/hot-flashes-causes-triggers-relief
Hot flashes are sudden waves of heat driven by changing estrogen levels affecting the brain's temperature control. They are the most common menopause symptom — and the most treatable.

### Night sweats in menopause: why they happen and what helps
Path: /blog/night-sweats-menopause-causes-relief
Night sweats are hot flashes that strike during sleep, driven by changing estrogen. They are treatable — and treating them often restores the sleep menopause has stolen.

### Menopause and sleep: why you wake at 3am and how to fix it
Path: /blog/menopause-sleep-problems-insomnia
Waking at 3am is one of the most common menopause complaints. The causes are hormonal — and most are treatable once you know what is driving them.

### Menopause, anxiety, and mood changes: what helps
Path: /blog/menopause-and-anxiety-mood
Mood changes in menopause are hormone-driven, not a personal failing. Here is what the evidence supports — and when to seek more help.

### Menopause brain fog: is it real, and what helps?
Path: /blog/menopause-brain-fog
Brain fog in menopause is real, common, and usually temporary. It tracks with fluctuating estrogen and disrupted sleep — not cognitive decline. Here is what the evidence supports.

### Menopause weight gain: what changes and what actually works
Path: /blog/menopause-weight-gain
Weight gain around menopause is driven by aging metabolism, muscle loss, and a hormonal shift in where fat is stored. Here is what changes — and what the evidence says actually works.

### Menopause joint pain: why your joints ache and what to do
Path: /blog/menopause-joint-pain
Aching, stiff joints are a common and under-recognized menopause symptom tied to falling estrogen. Here is why it happens and what the evidence says helps.

### Menopause, skin, and hair: changes and evidence-based care
Path: /blog/menopause-skin-and-hair-changes
Menopause changes skin and hair as estrogen falls — drier, thinner skin, lost collagen, and shifting hair growth. Here is what happens and what the evidence supports.

### Vaginal dryness after menopause: causes and treatment
Path: /blog/vaginal-dryness-after-menopause
Vaginal dryness after menopause is caused by falling estrogen thinning the vaginal tissue. It is common, treatable, and unlikely to improve without treatment — and local therapy works well.

### Painful sex after menopause: causes and treatment (GSM)
Path: /blog/painful-sex-after-menopause-gsm
Painful sex after menopause, known medically as dyspareunia, is a common symptom of the genitourinary syndrome of menopause. It is caused by low estrogen thinning vaginal tissue — and it is highly treatable.

### Low libido in menopause: causes and evidence-based options
Path: /blog/low-libido-menopause-options
Low libido in menopause is common and usually has several causes at once — hormonal shifts, painful intimacy, poor sleep, and mood. Here is what the evidence supports, and an honest look at where testosterone fits.

### Recurrent UTIs after menopause: the hormonal link
Path: /blog/recurrent-utis-after-menopause
Recurrent UTIs after menopause are often driven by falling estrogen, which changes the vaginal and urinary tissue and microbiome. Vaginal estradiol can reduce how often they return.

### How long can you stay on hormone therapy?
Path: /blog/how-long-can-you-stay-on-hrt
Current guidelines no longer set an arbitrary cutoff for hormone therapy. Duration is decided one year at a time, weighing your symptoms against your personal risk profile.

### Estradiol patch vs gel vs pill: how to choose
Path: /blog/estradiol-patch-vs-gel-vs-pill
All three deliver the same body-identical estradiol. The real decision is transdermal versus oral — a route choice with meaningful implications for clot risk and convenience.

### Micronized progesterone: benefits, timing, and side effects
Path: /blog/micronized-progesterone-guide
If you take estrogen and have a uterus, micronized progesterone protects the uterine lining. Taken at bedtime, it also tends to help with sleep.

### Hormone therapy side effects: what to expect and when to call
Path: /blog/hormone-therapy-side-effects
Early side effects are usually mild and fade as your body adjusts. Knowing which are normal — and which are warning signs — helps you stay on treatment safely.

### Who should not take hormone therapy?
Path: /blog/who-should-not-take-hrt-contraindications
Hormone therapy suits most healthy women near menopause, but not everyone. Here are the conditions that rule it out, the ones that call for caution, and why low-dose vaginal therapy is often still an option.

### Non-hormonal options for menopause: what the evidence says
Path: /blog/non-hormonal-options-for-menopause
Hormone therapy is the most effective treatment for hot flashes, but it is not the only one. Here are the non-hormonal options with real evidence behind them — and how to tell them apart from the supplements that don't deliver.

### Menopause and heart health: what changes and what helps
Path: /blog/menopause-and-heart-health
Heart disease is the leading cause of death in women, and risk shifts during menopause. Here is what changes, what the trials say about hormone therapy and the heart, and how to protect yourself.

### Perimenopause symptoms: when it starts and how long it lasts
Path: /blog/perimenopause-symptoms-and-timeline
What age does perimenopause start, and how long does it last? Here is the typical timeline and the full symptom list — for how perimenopause differs from menopause itself, see our companion guide.

### How much does HRT cost? What women actually pay
Path: /blog/how-much-does-hrt-cost
There is no single price for HRT. What you pay depends on the pricing model — insurance copays plus visit fees, a monthly membership, or à-la-carte cash-pay — and on what that price quietly includes or leaves out.

### How to get HRT online: what the process actually looks like
Path: /blog/how-to-get-hrt-online
Getting HRT online means completing a symptom assessment, then having a live video or phone visit with a US-licensed clinician who evaluates whether therapy is appropriate. A questionnaire alone is a red flag — a real visit is the standard.

### The WHI study explained: what the numbers actually showed
Path: /blog/whi-study-explained
The 2002 Women's Health Initiative changed how a generation viewed hormone therapy — largely through relative-risk headlines applied to an older cohort. Read in absolute terms, and in light of the timing hypothesis, the picture is more nuanced than the scare stories.

### Fezolinetant vs paroxetine vs gabapentin for hot flashes
Path: /blog/fezolinetant-paroxetine-gabapentin-compared
If hormone therapy is not right for you, four prescription medications have real evidence for hot flashes: fezolinetant, low-dose paroxetine, venlafaxine, and gabapentin. Here is how they compare, drug by drug.

### Estrogen and the liver: oral vs transdermal, explained
Path: /science/estrogen-and-the-liver
Swallowed estrogen meets the liver before it meets the rest of you, and that single fact drives most of the route decision in hormone therapy. Here is what first-pass metabolism actually changes, and who it matters for.

### Progesterone and sleep: why it helps, when to take it
Path: /blog/progesterone-and-sleep
Micronized progesterone is the only part of standard hormone therapy that is routinely mildly sedating, and prescribers use that on purpose. Here is why it makes you drowsy, and how the bedtime convention works.

### How to cancel Winona: steps, refunds, and timing
Path: /blog/how-to-cancel-winona
Winona cancellations happen inside your account, and refunds only exist inside a 24-hour processing window. Here is the exact path, what to check first, and how to keep your hormone therapy uninterrupted.

### How to cancel Alloy: steps, deadlines, and refunds
Path: /blog/how-to-cancel-alloy
Alloy cancellations are per product, inside your account, and they need five business days before your next shipment processes. Here is the path, the refund fine print, and how to switch without a treatment gap.

### How to cancel Evernow: membership and annual plans
Path: /blog/how-to-cancel-evernow
Evernow is a membership service, so cancelling means ending the membership, and prepaid plans generally run to the end of their term. Here is how to do it cleanly and keep your treatment uninterrupted.

### How to cancel Midi Health: visits and subscriptions
Path: /blog/how-to-cancel-midi
Midi is two different things to cancel: appointments, which need 24 hours notice to avoid a fee, and subscriptions, which need notice before renewal. Here are both paths, verified against Midi's own terms.

## Contact
care@womea.com